Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Prostate Cancer

Free Subscription Articles published in Radiology Retrieve available abstracts of 38 articles: HTML format

Single Articles

September 2022
1. PARIHAR AS, Hofman MS, Iravani A
   (177)Lu-Prostate-specific Membrane Antigen Radioligand Therapy in Patients with Metastatic Castration-resistant Prostate Cancer.
   Radiology. 2022 Sep 20:220859. doi: 10.1148/radiol.220859.
   PubMed     Abstract available
   
   
   August 2022
2. GOH V
   Tumor Physiology and Clinically Significant Prostate Cancer Detection.
   Radiology. 2022 Aug 16:221798. doi: 10.1148/radiol.221798.
   PubMed    
   
   
   
3. TAVAKOLI AA, Hielscher T, Badura P, Gortz M, et al
   Contribution of Dynamic Contrast-enhanced and Diffusion MRI to PI-RADS for Detecting Clinically Significant Prostate Cancer.
   Radiology. 2022 Aug 16:212692. doi: 10.1148/radiol.212692.
   PubMed     Abstract available
   
   
   
4. SINGH S, Rogers H, Kanber B, Clemente J, et al
   Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study.
   Radiology. 2022 Aug 2:212536. doi: 10.1148/radiol.212536.
   PubMed     Abstract available
   
   
   July 2022
5. LEE GH, Chatterjee A, Karademir I, Engelmann R, et al
   Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer with Multiparametric versus Hybrid Multidimensional MRI.
   Radiology. 2022 Jul 26:211895. doi: 10.1148/radiol.211895.
   PubMed     Abstract available
   
   
   
6. TURKBEY B
   Hybrid Multidimensional Prostate MRI: A Quantitative Step in the Right Direction.
   Radiology. 2022 Jul 26:221452. doi: 10.1148/radiol.221452.
   PubMed    
   
   
   
7. ZUKOTYNSKI KA, Kuo PH
   (18)F-DCFPyL PET/CT in Men with Prostate Cancer.
   Radiology. 2022 Jul 19:221536. doi: 10.1148/radiol.221536.
   PubMed    
   
   
   
8. ULANER GA, Thomsen B, Bassett J, Torrey R, et al
   (18)F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic Confirmation.
   Radiology. 2022 Jul 19:220218. doi: 10.1148/radiol.220218.
   PubMed     Abstract available
   
   
   
9. GHAI S, Perlis N, Atallah C, Jokhu S, et al
   Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men.
   Radiology. 2022 Jul 19:212163. doi: 10.1148/radiol.212163.
   PubMed     Abstract available
   
   
   May 2022
10. JADVAR H
    Prostate-specific Membrane Antigen PET: Standard Imaging in Prostate Cancer.
    Radiology. 2022 May 24:221074. doi: 10.1148/radiol.221074.
    PubMed    
    
    
    
11. BASSO DIAS A, Finelli A, Bauman G, Veit-Haibach P, et al
    Impact of (18)F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer.
    Radiology. 2022 May 24:211836. doi: 10.1148/radiol.211836.
    PubMed     Abstract available
    
    
    
12. HAIDER MA
    It's Time for a Standardized MRI Assessment Scheme for Prostate Cancer Recurrence.
    Radiology. 2022 May 10:220701. doi: 10.1148/radiol.220701.
    PubMed    
    
    
    
13. PECORARO M, Turkbey BI, Purysko AS, Girometti R, et al
    Diagnostic Accuracy and Observer Agreement of the MRI Prostate Imaging for Recurrence Reporting Assessment Score.
    Radiology. 2022 May 10:212252. doi: 10.1148/radiol.212252.
    PubMed     Abstract available
    
    
    March 2022
14. WU D, Jiang K, Li H, Zhang Z, et al
    Time-Dependent Diffusion MRI for Quantitative Microstructural Mapping of Prostate Cancer.
    Radiology. 2022 Mar 8:211180. doi: 10.1148/radiol.211180.
    PubMed     Abstract available
    
    
    
15. CHATTERJEE A, Oto A
    Prostate Tissue Microstructural Estimates Using Time-Dependent Diffusion MRI.
    Radiology. 2022 Mar 8:220056. doi: 10.1148/radiol.220056.
    PubMed    
    
    
    February 2022
16. KUMAR R, Singh SK, Mittal BR, Vadi SK, et al
    Safety and Diagnostic Yield of (68)Ga Prostate-specific Membrane Antigen PET/CT Guided Robotic-assisted Transgluteal Prostatic Biopsy.
    Radiology. 2022 Feb 22:204066. doi: 10.1148/radiol.204066.
    PubMed     Abstract available
    
    
    
17. UEDA T, Ohno Y, Yamamoto K, Murayama K, et al
    Deep Learning Reconstruction of Diffusion-weighted MRI Improves Image Quality for Prostatic Imaging.
    Radiology. 2022 Feb 1:204097. doi: 10.1148/radiol.204097.
    PubMed     Abstract available
    
    
    January 2022
18. CIVELEK AC
    Management of Metastatic Prostate Cancer Biochemical Recurrence with Use of (18)F-DCFPyL PET/CT.
    Radiology. 2022 Jan 25:212993. doi: 10.1148/radiol.212993.
    PubMed    
    
    
    
19. METSER U, Zukotynski K, Mak V, Langer D, et al
    Effect of (18)F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial.
    Radiology. 2022 Jan 25:211824. doi: 10.1148/radiol.211824.
    PubMed     Abstract available
    
    
    
20. RANASINGHE WKB, Troncoso P, Surasi DS, Ibarra Rovira JJ, et al
    Defining Diagnostic Criteria for Prostatic Ductal Adenocarcinoma at Multiparametric MRI.
    Radiology. 2022 Jan 25:204732. doi: 10.1148/radiol.204732.
    PubMed     Abstract available
    
    
    
21. LAMBERG H, Shankar PR, Singh K, Caoili EM, et al
    Preoperative Prostate MRI Predictors of Urinary Continence Following Radical Prostatectomy.
    Radiology. 2022 Jan 18:210500. doi: 10.1148/radiol.210500.
    PubMed     Abstract available
    
    
    
22. KANAS AF, Fenelon SS, Santos JMMM, Coelho RF, et al
    Case 297: Mucinous Adenocarcinoma of the Prostate.
    Radiology. 2022;302:238-242.
    PubMed     Abstract available
    
    
    December 2021
23. GOTTLIEB RH
    Introducing a Standard in Prostate Cancer Imaging Evaluation.
    Radiology. 2021 Dec 21:212111. doi: 10.1148/radiol.212111.
    PubMed    
    
    
    
24. WIBMER AG, Nikolovski I, Chaim J, Lakhman Y, et al
    Local Extent of Prostate Cancer at MRI versus Prostatectomy Histopathology: Associations with Long-term Oncologic Outcomes.
    Radiology. 2021 Dec 21:210875. doi: 10.1148/radiol.210875.
    PubMed     Abstract available
    
    
    November 2021
25. CHATTERJEE A, Mercado C, Bourne RM, Yousuf A, et al
    Validation of Prostate Tissue Composition by Using Hybrid Multidimensional MRI: Correlation with Histologic Findings.
    Radiology. 2021 Nov 9:204459. doi: 10.1148/radiol.2021204459.
    PubMed     Abstract available
    
    
    
26. WILLIAMS HT, Estes TL
    Anatomic and Functional Prostate Cancer Imaging.
    Radiology. 2021;301:E418.
    PubMed    
    
    
    October 2021
27. KANG SK, Mali RD, Prabhu V, Ferket BS, et al
    Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.
    Radiology. 2021;301:E380.
    PubMed    
    
    
    August 2021
28. WILLIAMS HT, Estes TL
    Anatomic and Functional Prostate Cancer Imaging.
    Radiology. 2021 Aug 31:211837. doi: 10.1148/radiol.2021211837.
    PubMed    
    
    
    
29. MARGEL D, Bernstine H, Groshar D, Ber Y, et al
    Diagnostic Performance of (68)Ga Prostate-specific Membrane Antigen PET/MRI Compared with Multiparametric MRI for Detecting Clinically Significant Prostate Cancer.
    Radiology. 2021 Aug 31:204093. doi: 10.1148/radiol.2021204093.
    PubMed     Abstract available
    
    
    July 2021
30. KANG SK, Mali RD, Prabhu V, Ferket BS, et al
    Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.
    Radiology. 2021 Jul 13:204321. doi: 10.1148/radiol.2021204321.
    PubMed     Abstract available
    
    
    May 2021
31. DENIFFEL D, Healy GM, Dong X, Ghai S, et al
    Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer.
    Radiology. 2021 May 25:204112. doi: 10.1148/radiol.2021204112.
    PubMed     Abstract available
    
    
    
32. LI M, Guo J, Hu P, Jiang H, et al
    Tomoelastography Based on Multifrequency MR Elastography for Prostate Cancer Detection: Comparison with Multiparametric MRI.
    Radiology. 2021;299:E259.
    PubMed    
    
    
    
33. GHAI S, Finelli A, Corr K, Chan R, et al
    MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.
    Radiology. 2021;299:E258.
    PubMed    
    
    
    
34. GOLDBERG SN
    More Interventional Oncologic Fire from COLDFIRE-2.
    Radiology. 2021;299:481-482.
    PubMed    
    
    
    April 2021
35. HARMON SA, Gesztes W, Young D, Mehralivand S, et al
    Prognostic Features of Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy Based on Multiparametric MRI and Immunohistochemistry Analysis of MRI-guided Biopsy Specimens.
    Radiology. 2021 Apr 13:202425. doi: 10.1148/radiol.2021202425.
    PubMed     Abstract available
    
    
    
36. COSTA DN
    Multiparametric MRI of the Prostate: Beyond Cancer Detection and Staging.
    Radiology. 2021 Apr 13:204506. doi: 10.1148/radiol.2021204506.
    PubMed    
    
    
    February 2021
37. TEMPANY-AFDHAL CMC, Padhani A, Barentsz J, Weinreb J, et al
    Perspectives and Concerns about PI-RADS and Variability.
    Radiology. 2021;298:E112.
    PubMed    
    
    
    November 2020
38. BAZARGANI S, Bandyk M, Balaji KC
    Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: What about the Negatives?
    Radiology. 2020 Nov 3:202870. doi: 10.1148/radiol.2020202870.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: